Page last updated: 2024-11-07

12-(9-anthroyloxy)stearic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

12-(9-anthroyloxy)stearic acid: emits radioluminescence when excited by radioactive decay of tritium [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121860
SCHEMBL ID593057
MeSH IDM0087321

Synonyms (16)

Synonym
9-anthracenecarboxylic acid, 11-carboxy-1-hexylundecyl ester
12-(9-anthroyloxy)stearic acid
30536-60-8
12-(anthracene-9-carbonyloxy)octadecanoic acid
12-as cpd
039y7q32co ,
unii-039y7q32co
SCHEMBL593057
(+-)-12-(9-anthroyloxy)stearic acid
12-(9-anthroyloxy)stearic acid, (+/-)-
12-((anthracene-9-carbonyl)oxy)octadecanoic acid
FT-0697039
Q27247549
12-[(anthracene-9-carbonyl)oxy]octadecanoic acid
DTXSID80952836
12-((anthracene-9-carbonyl)oxy)octadecanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (44.83)18.7374
1990's8 (27.59)18.2507
2000's8 (27.59)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.81

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.81 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.81)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]